Puretech Health plc (PRTC) Ordinary 1p

Sell:131.80pBuy:133.00p1.00p (0.75%)

FTSE All Share:0.87%
Market closed |
Prices delayed by at least 15 minutes
Sell:131.80p
Buy:133.00p
Change:1.00p (0.75%)
Market closed |
Prices delayed by at least 15 minutes
Sell:131.80p
Buy:133.00p
Change:1.00p (0.75%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 September 2025
Robert LyneCEO
Buy
Regular purchase transaction
81,051£1.23£99,692.730
22 September 2025
John L. LaMattinaIndependent Director
Buy
Regular purchase transaction
59,100£1.25£73,875.001,521,737
22 September 2025
Sharon Barber-LuiChairman of the Board
Buy
Regular purchase transaction
65,250£1.24£80,910.00163,081
22 September 2025
Michele HolcombIndependent Director
Buy
Regular purchase transaction
29,239£1.25£36,548.7579,239
1 July 2025
Robert LyneCEO
Sell
Regular sell transaction (market)
33,561125.05p4,196,803.05p0
1 July 2025
Robert LyneCEO
Buy
Regular purchase transaction
33,561125.78p4,221,302.58p0

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 July 2025
Robert LyneCEO
Buy
Regular purchase transaction
33,561125.78p4,221,302.58p0
1 July 2025
Robert LyneCEO
Sell
Regular sell transaction (market)
33,561125.05p4,196,803.05p0
22 September 2025
Robert LyneCEO
Buy
Regular purchase transaction
81,051£1.23£99,692.730
22 September 2025
Sharon Barber-LuiChairman of the Board
Buy
Regular purchase transaction
65,250£1.24£80,910.00163,081
22 September 2025
John L. LaMattinaIndependent Director
Buy
Regular purchase transaction
59,100£1.25£73,875.001,521,737

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.